COVID-19
Pfizer vaccine: Study finds increased breakthrough rates of South African variant
April 19, 2021Sales and Marketing COVID-19, Pfizer, Vaccine, variant
A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …
Merck cease development of $425 million COVID-19 treatment
April 16, 2021Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news
Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.
EMA to begin review of GSK and Vir’s COVID-19 treatment
April 16, 2021Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …
Pharmafile.com’s weekly COVID-19 news round-up
April 14, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen plenty of good and bad COVID-19 vaccine news; the EMA and CDC have launched investigations …
AstraZeneca’s Farxiga falls short in Phase III trials for treatment of COVID-19
April 13, 2021Manufacturing and Production AstraZeneca, COVID-19, covid-19 treatment, farxiga, pharma, pharma news
AstraZeneca’s Farxiga drug, usually used in patients with diabetes, did not show statistical significance in the Phase III trial into …
Regeneron’s drug cocktail shown to prevent symptomatic COVID-19
April 13, 2021Manufacturing and Production COVID-19, REGEN-COV, Regeneron, covid-19 treatment, pharma, pharma news
Regeneron’s REGEN-COV treatment cocktail for COVID-19, a combination between casirivimab and imdevimab, has shown a significant reduction in progression to …
Asthma drug Budesonide helps COVID-19 recovery at home
April 13, 2021Manufacturing and Production COVID-19, asthma drug
Budesonide, a widely-used asthma drug, is the first treatment to be proven to speed up the recovery of COVID-19 patients …
EMA launch investigation into J&J’s COVID-19 vaccine amid US blood clot reports
April 12, 2021Sales and Marketing COVID-19, EMA, J&J, JJ, Vaccine
The EMA is reviewing reports of rare blood clots in four people in the US who received Johnson & Johnson’s …
Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint
April 9, 2021Medical Communications COVID-19, Eli Lily
Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …
Pharmafile.com’s weekly COVID-19 news round-up
April 7, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen plenty of COVID-19 vaccine news; AstraZeneca has halted the paediatric trial of their jab amid …
UK begins rollout of Moderna COVID-19 vaccine
April 7, 2021Research and Development COVID-19, COVID-19 vaccine, Moderna, Moderna vaccine, pharma, pharma news
The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …
AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe
April 7, 2021Research and Development AstraZeneca, COVID-19, Vaccine
AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …
Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial
April 6, 2021Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine
Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …
Pfizer vaccine 91.3% effective after six months, Phase III study shows
April 6, 2021Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine
Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …
Pharmafile.com’s top 10 news stories of the week
April 2, 2021COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news
In the last week, a number of new COVID-19 developments have emerged; Novavax has delayed 100 million vaccines to the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
